APA (7th ed.) Citation

T, H., CC, M., S, A., A, N., & AM, B. (2021). Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management. Frontiers in endocrinology, 12, 713700. https://doi.org/10.3389/fendo.2021.713700

Chicago Style (17th ed.) Citation

T, Hyder, Marino CC, Ahmad S, Nasrazadani A, and Brufsky AM. "Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management." Frontiers in Endocrinology 12 (2021): 713700. https://doi.org/10.3389/fendo.2021.713700.

MLA (9th ed.) Citation

T, Hyder, et al. "Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management." Frontiers in Endocrinology, vol. 12, 2021, p. 713700, https://doi.org/10.3389/fendo.2021.713700.